Hurley Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-396
Closed -$11.7K 741
2025
Q4
$11.7K Hold
396
0.01% 310
2025
Q3
$10K Buy
396
+2
+0.5% +$49 0.01% 368
2025
Q2
$9.45K Buy
394
+6
+2% +$139 0.01% 314
2025
Q1
$8.88K Hold
388
0.01% 333
2024
Q4
$9.7K Buy
+388
New +$9.83K 0.01% 287

Other funds holding RTO

Hurley Capital's RTO Position: Q1 2026 in Review

Hurley Capital sold out of Rentokil (RTO) in Q1 2026, closing a stake of 396 shares — an estimated $11.7K sold.

Hurley Capital first reported a position in RTO in Q4 2024 and held it in 5 quarters. The position peaked at $11.7K in Q4 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Hurley Capital reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • Hurley Capital sold 396 Rentokil shares in Q1 2026, an estimated $11.7K.
  • Hurley Capital first reported a position in Rentokil in Q4 2024 and held it in 5 quarters.
  • Hurley Capital's Rentokil position peaked at $11.7K in Q4 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.